NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Age-Related Eye Disease Study (AREDS) and AREDS2 Follow-Up

This study is NOT currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

08-EI-0043

Sponsoring Institute

National Eye Institute (NEI)

Recruitment Detail

Type: No longer recruiting/follow-up only
Gender: Male & Female
Min Age: 50 Years
Max Age: 100 Years

Referral Letter Required

Yes

Population Exclusion(s)

Children

Keywords

Cataract;
Age-Related Macular Degeneration;
Age-Related Macular Degeneration (AMD);
Cataracts;
Natural History

Recruitment Keyword(s)

Age Related Macular Degeneration;
AMD;
Cataract

Condition(s)

Age-Related Macular Degeneration;
Cataract

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Eye Institute

This study is a 5-year extension of the AREDS protocol, in which investigators followed the natural course of age-related macular degeneration (AMD) and cataracts. Participants in the former AREDS protocol are eligible for this study.

Participants have a complete eye examination once a year and are contacted at least once a year between visits to check on their status. The eye examination includes measurement of visual acuity (vision chart test) and examination of the inside of the eye after the pupils have been dilated with eye drops. Photographs of the inside of the eye may be taken using a special camera that flashes a bright light in the eye. A blood sample may be obtained to test for cholesterol level and genes related to inflammation.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

Participants will be eligible if they:

-Were enrolled in the AREDS or AREDS2 protocol and successfully completed the final AREDS or AREDS2 follow-up visit.

-Can understand and provide informed consent.

EXCLUSION CRITERIA:

Participants will not be eligible if they:

-Are under the age of 50.

-Are not able to return to NIH for examination for the duration of the trial.

-Have any systemic diseases that compromise the ability to provide adequate ophthalmologic examination.


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Emily Y. Chew, M.D.
National Eye Institute (NEI)
NIHBC 10 - CRC BG RM 3-2531
10 CENTER DR
BETHESDA MD 20892
(301) 496-6583
echew@nei.nih.gov

Cathy Kangale-Whitney, R.N.
National Eye Institute (NEI)
National Institutes of Health
Building 10
Room 10D45
10 Center Drive
Bethesda, Maryland 20892
(301) 402-4174
cathy.kangale-whitney@nih.gov

Office of Patient Recruitment
National Institutes of Health Clinical Center (CC)
Building 61, 10 Cloister Court
Bethesda, Maryland 20892
Toll Free: 1-800-411-1222
Local Phone: 301-451-4383
TTY: TTY Users Dial 7-1-1
ccopr@nih.gov

Clinical Trials Number:

NCT00594672

--Back to Top--